Portugal: manufacture of pharmaceutical products production value 2020

The production value of the basic pharmaceutical products and pharmaceutical preparations manufacturing industry in Portugal increased by 238.6 million euros (+17.92 percent) in 2020. With 1.6 billion euros, the production value thereby reached its highest value in the observed period.
The production value is defined as turnover, plus or minus the changes in stocks of finished products, work in progress and goods and services purchased for resale, minus the purchases of goods and services for resale, plus capitalized production, plus other operating income (excluding subsidies). Income and expenditure classified as financial or extra-ordinary in company accounts is excluded from production value.

Find more statistics on the basic pharmaceutical products and pharmaceutical preparations manufacturing industry in Portugal with key insights such as turnover and personnel costs.

Production value of the manufacture of basic pharmaceutical products and pharmaceutical preparations in Portugal from 2011 to 2020 (in million euros)

Characteristic	Annual production value in million euros
2020	1,569.9
2019	1,331.3
2018	1,247.7
2017	1,141.4
2016	1,065
2015	1,064
2014	970.9
2013	1,027.7
2012	1,106.8
2011	1,012.5

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

March 2023

More information

Region

Portugal

Survey time period

2011 to 2020

Supplementary notes

The source adds the following information: Production value measures the amount actually produced by the unit, based on sales, including changes in stocks and the resale of goods and services. The production value is defined as turnover, plus or minus the changes in stocks of finished products, work in progress and goods and services purchased for resale, minus the purchases of goods and services for resale, plus capitalised production, plus other operating income (excluding subsidies). Income and expenditure classified as financial or extra-ordinary in company accounts is excluded from production value.
Data coverage corresponds to Section C21 of NACE Rev2.

Citation formats